361 related articles for article (PubMed ID: 8690045)
1. Lineage commitment of CD34+ human hematopoietic progenitor cells.
Tjønnfjord GE; Steen R; Veiby OP; Egeland T
Exp Hematol; 1996 Jul; 24(8):875-82. PubMed ID: 8690045
[TBL] [Abstract][Full Text] [Related]
2. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells.
Gaipa G; Coustan-Smith E; Todisco E; Maglia O; Biondi A; Campana D
Haematologica; 2002 Apr; 87(4):347-56. PubMed ID: 11940478
[TBL] [Abstract][Full Text] [Related]
3. CD3 gamma, CD3 delta, and CD3 zeta mRNA in adult human marrow hematopoietic progenitors correlates with surface CD2 and CD7 expression.
Long H; Gaffney P; Mortari F; Miller JS
Exp Hematol; 1996 Oct; 24(12):1402-8. PubMed ID: 8913286
[TBL] [Abstract][Full Text] [Related]
4. T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34(+)CD38(-)CD7(+) common lymphoid progenitors expressing lymphoid-specific genes.
Hoebeke I; De Smedt M; Stolz F; Pike-Overzet K; Staal FJ; Plum J; Leclercq G
Leukemia; 2007 Feb; 21(2):311-9. PubMed ID: 17170726
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients.
D'Arena G; Cascavilla N; Musto P; Greco M; Di Mauro L; Carella AM; Dello Iacono N; Carotenuto M
Haematologica; 1996; 81(3):216-23. PubMed ID: 8767526
[TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord blood: immunophenotypic heterogeneity of CD34+ hematopoietic progenitor cells.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Zendoli F; Carotenuto M
Haematologica; 1996; 81(5):404-9. PubMed ID: 8952152
[TBL] [Abstract][Full Text] [Related]
7. Age-related changes in human hematopoietic stem/progenitor cells.
Kuranda K; Vargaftig J; de la Rochere P; Dosquet C; Charron D; Bardin F; Tonnelle C; Bonnet D; Goodhardt M
Aging Cell; 2011 Jun; 10(3):542-6. PubMed ID: 21418508
[TBL] [Abstract][Full Text] [Related]
8. T cell differentiation/maturation of CD34+ stem cells from HIV-seropositive hemophiliacs in cultured thymic epithelial fragments.
Ruiz M; Roodman ST; Bouhasin JD; Knutsen AP
Stem Cells; 1996 Jan; 14(1):132-45. PubMed ID: 8820959
[TBL] [Abstract][Full Text] [Related]
9. Expression of stromal cell-derived factor-1/pre-B cell growth-stimulating factor receptor, CXC chemokine receptor 4, on CD34+ human bone marrow cells is a phenotypic alteration for committed lymphoid progenitors.
Ishii T; Nishihara M; Ma F; Ebihara Y; Tsuji K; Asano S; Nakahata T; Maekawa T
J Immunol; 1999 Oct; 163(7):3612-20. PubMed ID: 10490954
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD7 on normal human myeloid progenitors.
Chabannon C; Wood P; Torok-Storb B
J Immunol; 1992 Sep; 149(6):2110-3. PubMed ID: 1381397
[TBL] [Abstract][Full Text] [Related]
11. Distinct alterations in lineage committed progenitor cells exist in the peripheral blood of patients with rheumatoid arthritis and primary Sjogren's syndrome.
Santiago-Schwarz F; Sullivan C; Rappa D; Carsons SE
J Rheumatol; 1996 Mar; 23(3):439-46. PubMed ID: 8832979
[TBL] [Abstract][Full Text] [Related]
12. Generation of dendritic cells from lymphoid precursors.
Galy A
Methods Mol Med; 2001; 64():275-81. PubMed ID: 21374267
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
Grassinger J; Mueller G; Zaiss M; Kunz-Schughart LA; Andreesen R; Hennemann B
Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909
[TBL] [Abstract][Full Text] [Related]
14. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
15. Prethymic CD34+ progenitors capable of developing into T cells are not committed to the T cell lineage.
Blom B; Res P; Noteboom E; Weijer K; Spits H
J Immunol; 1997 Apr; 158(8):3571-7. PubMed ID: 9103417
[TBL] [Abstract][Full Text] [Related]
16. Characterization of CD7+CD19+ lymphoid cells after Epstein-Barr virus transformation.
Panzer-Grümayer ER; Panzer S; Wolf M; Majdic O; Haas OA; Kersey JH
J Immunol; 1993 Jul; 151(1):92-9. PubMed ID: 7686950
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection.
Inaba T; Shimazaki C; Hirata T; Ashihara E; Okawa K; Oku N; Goto H; Fujita N; Tsuji H; Nakagawa M
Bone Marrow Transplant; 1994 May; 13(5):527-32. PubMed ID: 7519935
[TBL] [Abstract][Full Text] [Related]
18. T-lymphopoietic capacity of cord blood-derived CD34+ progenitor cells.
Gardner JP; Rosenzweig M; Marks DF; Harper D; Gaynor K; Fallon RJ; Wall DA; Johnson RP; Scadden DT
Exp Hematol; 1998 Sep; 26(10):991-9. PubMed ID: 9728935
[TBL] [Abstract][Full Text] [Related]
19. Emergence of T, B, and myeloid lineage-committed as well as multipotent hemopoietic progenitors in the aorta-gonad-mesonephros region of day 10 fetuses of the mouse.
Ohmura K; Kawamoto H; Fujimoto S; Ozaki S; Nakao K; Katsura Y
J Immunol; 1999 Nov; 163(9):4788-95. PubMed ID: 10528178
[TBL] [Abstract][Full Text] [Related]
20. Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allografts.
Theilgaard-Mönch K; Raaschou-Jensen K; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E
Bone Marrow Transplant; 2003 Dec; 32(12):1125-33. PubMed ID: 14647266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
